This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Levi, F. A. Articles by Kennedy, B. J. Search for Related Content PubMed PubMed Citation Articles by Levi, F. A. Articles by Kennedy, B. J.

Reduction of cis-Diamminedichloroplatinum Nephrotoxicity in Rats by Optimal Circadian Drug Timing¹

Section of Medical Oncology and Chronobiology Laboratories, University of Minnesota, Minneapolis, Minnesota 55455 [F. A. L., W. J. M. H., F. H., B. J. K.], and Department of Anatomic and Clinical Pathology, St. Paul-Ramsey Medical Center, St. Paul, Minnesota 55101 [C. H. B., D. J. L., E. H.]

A prominent circadian rhythm in the nephrotoxicity of a therapeutic dose of cis-diamminedichloroplatinum (cisplatin) is demonstrated in female Fischer rats. Rats were randomized to receive two doses of either cisplatin or 0.9% NaCl solution 14 days apart at the times of either high or low values in their circadian rhythm of urinary volume.

Toxicity was assessed by measuring changes in body weight and changes in the 24-hr means of urinary volume, blood urea nitrogen, and urinary ß-N-acetylglucosaminidase (NAG) activity.

Toxicity was least in rats which received the drug near the circadian maximum of urinary volume. Conversely, rats which received the same dose of drug near the circadian minimum of urinary volume lost more weight and exhibited a 2-fold increase in the 24-hr mean of urinary volume, a 3-fold rise in the 24-hr mean of blood urea nitrogen, and a 5-fold increase in the 24-hr mean of urinary NAG activity.

A positive correlation between urinary NAG at the time of cisplatin administration and the extent of cisplatin nephrotoxicity was demonstrated (p < 0.02). A correlation also was found between tissue NAG concentration and tissue uptake of cisplatin (p < 0.001). A marked circadian rhythm of NAG activity in proximal tubular cells may contribute to the prominent circadian rhythm in murine renal tolerance for cisplatin.

¹ This work was supported by National Cancer Institute Grant CA-14445; St. Paul-Ramsey Medical Center Medical Education and Research Foundation Grant 88257; the Masonic Memorial Hospital Fund, Inc.; the Minnesota Medical Foundation; and the American Cancer Society. A portion of this work has been presented in abstract form (25).

² Recipient of a fellowship grant from the Daughters of Job of the Minnesota Masons.

³ American Cancer Society Junior Faculty Fellow, Grant No. 509A. To whom requests for reprints should be addressed.

Received 2/ 5/81. Accepted 12/ 9/81.

This article has been cited by other articles:

				W. Hrushesky Circadian timing of cancer chemotherapy Science, April 5, 1985; 228(4695): 73 - 75. [Abstract] [PDF]